WILSON THERAPEUTICS
Wilson Therapeutics is a biopharmaceutical company, based in Stockholm, Sweden, that develops novel therapies for patients with rare diseases such as Wilson Disease. Wilson Therapeutics’ lead product, Decuprate®, is initially being developed as a new treatment for Wilson Disease and is currently being evaluated in a Phase II clinical study in Wilson Disease patients.
WILSON THERAPEUTICS
Industry:
Biotechnology Health Care Therapeutics
Founded:
2012-01-01
Address:
Stockholm, Stockholms Lan, Sweden
Country:
Sweden
Website Url:
http://www.wilsontherapeutics.com
Total Employee:
11+
Status:
Active
Contact:
46 8 796 00 00
Email Addresses:
[email protected]
Total Funding:
68.89 M USD
Technology used in webpage:
IPhone / Mobile Compatible SPF SSL By Default Amazon PHP 7 Amazon Route 53 Apache 2.4
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Myelo Therapeutics
Myelo Therapeutics develops innovative treatments in areas of high unmet medical needs.
Quantum Genomics
Quantum Genomics is developing therapies for unmet medical needs in the field of cardiovascular diseases
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
MVM Life Science Partners
MVM Life Science Partners investment in Series B - Wilson Therapeutics
Neomed Management
Neomed Management investment in Series B - Wilson Therapeutics
HealthCap
HealthCap investment in Series B - Wilson Therapeutics
Abingworth
Abingworth investment in Series B - Wilson Therapeutics
Official Site Inspections
http://www.wilsontherapeutics.com
- Host name: s3-website.us-east-1.amazonaws.com
- IP address: 3.5.31.160
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
More informations about "Wilson Therapeutics"
Wilson Therapeutics - Crunchbase Company Profile & Funding
Wilson Therapeutics is a biopharmaceutical company, based in Stockholm, Sweden, that develops novel therapies for patients with rare diseases such as Wilson Disease. Wilson …See details»
Wilson Therapeutics AB - Ownership and Business Overview
Apr 11, 2018 Wilson Therapeutics’ product, WTX101, is in Phase 3 development as a novel treatment for Wilson disease. Company Summary. SECTOR. Life Science. Employees. 13. …See details»
Wilson Therapeutics - Craft
Wilson Therapeutics is a biopharmaceutical company that develops novel therapies for patients with rare diseases such as Wilson Disease. Its lead product, Decuprate, is initially being …See details»
Wilson Therapeutics Company Profile 2024: Valuation, Investors ...
Abingworth, Fjärde AP-fonden, Flerie, Granite Point Capital, and HealthCap are 5 of 12 investors who have invested in Wilson Therapeutics. Who are Wilson Therapeutics’s competitors? BBS …See details»
Wilson Therapeutics | VentureRadar
Wilson Therapeutics is a privately-held biopharmaceutical company focused on improving the lives of patients with Wilson's disease through development of new treatment options and …See details»
Wilson Therapeutics Overview | SignalHire Company Profile
Wilson Therapeutics is a biopharmaceutical company, based in Stockholm, Sweden, that develops novel therapies for patients with rare diseases. Wilson Therapeutics’ lead product, …See details»
Wilson Therapeutics company information, funding & investors
Wilson Therapeutics Verified. Developing novel treatments for Wilson Disease. Launch date. 1984. Employees. 201-500 people. Market cap-Net debt-Enterprise valuation.See details»
Wilson Therapeutics - Contacts, Employees, Board Members
Organization. Wilson Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. ... Number of Board Member and Advisor Profiles 7. Contacts 1. …See details»
Wilson Therapeutics - Products, Competitors, Financials, …
Wilson Therapeutics is a privately-held biopharmaceutical company focused on improving the lives of patients with Wilson's disease through development of new treatment options and …See details»
Wilson Therapeutics CEO and Key Executive Team | Craft.co
Wilson Therapeutics's CEO is Jonas Hansson. Other executives include David Clark, CMO; Thomas Plitz, CSO and 3 others. See the full leadership team at Craft.See details»
Wilson Therapeutics AB announces public offer from Alexion ...
Apr 11, 2018 “Alexion places great value on Wilson Therapeutics’ management team and employees, and expects that the Offer will support further growth and create long term positive …See details»
Wilson Therapeutics (Sweden) Funding: $68.9M
Nov 26, 2024 Wilson Therapeutics is a biopharmaceutical company that committed to improving lives of patients with Wilson Disease through the development of new treatment options. …See details»
Wilson Therapeutics AB – Funding, Valuation, Investors, News
Wilson Therapeutics AB (publ) is a drug development company, that develops novel therapies for patients with rare diseases such as Wilson Disease. Patients with Wilson Disease suffer from …See details»
Wilson Therapeutics - Golden
Wilson Therapeutics. Wilson Therapeutics is an every Day We Change Lives founded in 1992. Overview Structured Data Issues Contributors Activity. Contents. wilsontherapeutics.com. Is a. …See details»
Wilson Therapeutics | Case study | Invest Europe
Wilson Therapeutics was founded to find and develop a treatment for Wilson’s Disease, a rare inherited condition characterised by excess build-up of copper in the body, which can lead to …See details»
What is Wilson Therapeutics? Company Culture, Mission, Values
Wilson Therapeutics. Is this your company? This employer has not claimed their Employer Profile and is missing out on connecting with our community. Connect with our community. Claim …See details»
Wilson Therapeutics - VentureRadar
" Wilson Therapeutics is a privately-held biopharmaceutical company focused on improving the lives of patients with Wilson's disease through development of new treatment options and …See details»
Lars Olsson - Vice President of Chemistry, Manufacturing
Dr. Lars Olsson joined Wilson Therapeutics in December 2012, with responsibility for all Chemistry, Manufacturing and Controls (CMC) activities. Dr. Olsson started his professional …See details»
Gene Therapy Pioneer Jim Wilson Comments on Solid …
17 hours ago Wilson is also the Chairperson of Franklin Biolabs, a Contract Research Organization. The collective goal of the two affiliated companies is to translate innovative …See details»
Device-assisted strategies for drug delivery across the blood-brain ...
2 days ago The blood-brain barrier, essential for protecting the central nervous system, also restricts drug delivery to this region. Thus, delivering drugs across the blood-brain barrier is an …See details»